Fig. 4

Administration of ruxolitinib decreased the contents of plasma IL-6, TNF-a, IL-1β, IFN-γ, IL-10 and IL-17 in rabbits with atherosclerosis. (a~f) The levels of plasma IL-6, IL-1β, IFN-γ, TNF-a, IL-10 and IL-17 in rabbits were detected by enzyme-linked immunosorbent assay kits. ^**P < 0.01 versus control group; ^##P < 0.01 versus model group. Data were analyzed by using Student’s t-test and expressed as mean ± SD (n = 3)